EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Klinik Hietzing, Medical University of Vienna, Zuyderland Medisch Centrum, University Medical Center Utrecht, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Karolinska Institutet, Hôpital Cochin, University of Leeds, Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leiden University Medical Center, University of Twente, Klinik und Poliklinik für Psychotherapie und Psychosomatik, Technische Universität Dresden, Amsterdam UMC Location Vrije Universiteit Amsterdam, Queen Elizabeth Hospital Birmingham, University of Birmingham, Wellcome Trust, Hospital for Special Surgery, Mount Sinai Hospital, University of Toronto, Cornell University, Université de Montpellier, University of Genoa, Maastricht University, University Hospital of Geneva, Fundación Ramón Domínguez, Sorbonne Université, Pitié-Salpêtrière Hospital, Centre National de la Recherche Scientifique, Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, Erasmus MC, University of Manchester, Arthritis UK, Association of Rheumatologists of Russia, European League Against Rheumatism, Diakonhjemmet Hospital, Peking University, Peking University People's Hospital, Université Paris-Sud, Inserm, Assistance Publique – Hôpitaux de Paris, University of Glasgow, The University of Queensland, Charles University, Institute of Rheumatology, Semmelweis University, Hôpital Pellegrin, Ziekenhuis Bernhoven, University of Cologne, University of Alabama at Birmingham, Hospitais da Universidade de Coimbra, Statistics Austria, Keio University Hospital, KU Leuven